Lymphoma

Showing NaN - NaN of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

Lymphoma Trial in United States (itacitinib, ibrutinib)

Completed
  • Lymphoma
  • Scottsdale, Arizona
  • +20 more
Nov 14, 2022

Lymphoma Trial in United States (biological, drug, radiation)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
Sep 23, 2022

Solid Tumor, Lymphoma Trial in China, United States (TJ011133, Pembrolizumab, Rituximab)

Active, not recruiting
  • Solid Tumor
  • Lymphoma
  • Birmingham, Alabama
  • +20 more
Aug 22, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

Active, not recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
Jul 20, 2022

Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
Mar 7, 2022

Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)

Completed
  • Lymphoma
  • Acute Lymphoblastic Leukemia
  • Apixaban
  • No systemic anticoagulant prophylaxis
  • Phoenix, Arizona
  • +95 more
Feb 10, 2022

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Lymphoma Trial in United States (biological, drug, radiation, procedure)

Completed
  • Lymphoma
  • Bleomycin Sulfate
  • +11 more
  • Tucson, Arizona
  • +94 more
Jun 10, 2021

Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in United States (fimepinostat, Rituximab, venetoclax)

Completed
  • Lymphoma
  • +10 more
  • Los Angeles, California
  • +10 more
May 5, 2021

Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,

Completed
  • Advanced Solid Tumors
  • +8 more
  • Modified FOLFOX6
  • +3 more
  • Duarte, California
  • +11 more
Feb 3, 2021

Lymphoma Trial in United States (filgrastim, rituximab, carboplatin)

Completed
  • Lymphoma
  • filgrastim
  • +8 more
  • Palo Alto, California
  • +103 more
Oct 23, 2020

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (OT-82 Dose Escalation, OT-82 Dose Expansion)

Recruiting
  • Lymphoma
  • +6 more
  • OT-82 Dose Escalation
  • OT-82 Dose Expansion
  • Birmingham, Alabama
  • +7 more
Oct 22, 2020

Adult Solid Tumor, Lymphoma Trial in United States (Geriatric Assessment Summary, Geriatric Assessment Targeted Recommendations,

Completed
  • Adult Solid Neoplasm
  • Lymphoma
  • Geriatric Assessment Summary
  • +2 more
  • Duarte, California
  • +18 more
Oct 15, 2020

Lymphoma Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

Completed
  • Lymphoma
  • Tucson, Arizona
  • +205 more
Mar 30, 2020

Lymphoma Trial in Australia, United States (RP4010)

Terminated
  • Lymphoma
  • Birmingham, Alabama
  • +10 more
Dec 26, 2019

Lymphoma Trial in Worldwide (asparaginase, cyclophosphamide, cytarabine)

Completed
  • Lymphoma
  • Birmingham, Alabama
  • +175 more
Jul 24, 2019

Leukemia, Lymphoma, Brain Tumor Trial in Ann Arbor (Education information system)

Completed
  • Leukemia
  • +2 more
  • Education information system
  • Ann Arbor, Michigan
    University of Michigan
Jul 26, 2019